vs
OGE ENERGY CORP.（OGE）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是OGE ENERGY CORP.的1.0倍（$772.1M vs $752.6M），Revvity净利率更高（12.7% vs 6.7%，领先6.1%），Revvity同比增速更快（5.9% vs 0.7%），过去两年Revvity的营收复合增速更高（9.0% vs 8.1%）
OGE能源集团是一家受监管的公用电力企业，核心子公司俄克拉荷马燃气电力公司为俄克拉荷马州及阿肯色州超84.3万用户提供服务，覆盖俄克拉荷马城大都会区150万居民，总部设于俄克拉荷马城市中心。集团原旗下天然气管道业务Enogex于2013年与CenterPoint Energy的中游业务合并组建为Enable Midstream。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
OGE vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.0倍
$752.6M
营收增速更快
RVTY
高出5.2%
0.7%
净利率更高
RVTY
高出6.1%
6.7%
两年增速更快
RVTY
近两年复合增速
8.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $752.6M | $772.1M |
| 净利润 | $50.2M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 15.0% | 14.5% |
| 净利率 | 6.7% | 12.7% |
| 营收同比 | 0.7% | 5.9% |
| 净利润同比 | -19.9% | 3.9% |
| 每股收益（稀释后） | — | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OGERVTY
| Q1 26 | $752.6M | — | ||
| Q4 25 | $701.7M | $772.1M | ||
| Q3 25 | $1.0B | $698.9M | ||
| Q2 25 | $719.7M | $720.3M | ||
| Q1 25 | $741.1M | $664.8M | ||
| Q4 24 | $744.7M | $729.4M | ||
| Q3 24 | $945.2M | $684.0M | ||
| Q2 24 | $644.1M | $691.7M |
净利润OGERVTY
| Q1 26 | $50.2M | — | ||
| Q4 25 | $69.2M | $98.4M | ||
| Q3 25 | $231.3M | $46.7M | ||
| Q2 25 | $107.5M | $53.9M | ||
| Q1 25 | $62.7M | $42.2M | ||
| Q4 24 | $101.9M | $94.6M | ||
| Q3 24 | $218.7M | $94.4M | ||
| Q2 24 | $102.3M | $55.4M |
毛利率OGERVTY
| Q1 26 | — | — | ||
| Q4 25 | 59.2% | — | ||
| Q3 25 | 62.2% | 53.6% | ||
| Q2 25 | 63.7% | 54.5% | ||
| Q1 25 | 56.3% | 56.5% | ||
| Q4 24 | 59.7% | — | ||
| Q3 24 | 63.0% | 56.3% | ||
| Q2 24 | 69.9% | 55.7% |
营业利润率OGERVTY
| Q1 26 | 15.0% | — | ||
| Q4 25 | 19.7% | 14.5% | ||
| Q3 25 | 33.2% | 11.7% | ||
| Q2 25 | 25.9% | 12.6% | ||
| Q1 25 | 18.0% | 10.9% | ||
| Q4 24 | 24.5% | 16.3% | ||
| Q3 24 | 33.1% | 14.3% | ||
| Q2 24 | 27.3% | 12.4% |
净利率OGERVTY
| Q1 26 | 6.7% | — | ||
| Q4 25 | 9.9% | 12.7% | ||
| Q3 25 | 22.5% | 6.7% | ||
| Q2 25 | 14.9% | 7.5% | ||
| Q1 25 | 8.5% | 6.4% | ||
| Q4 24 | 13.7% | 13.0% | ||
| Q3 24 | 23.1% | 13.8% | ||
| Q2 24 | 15.9% | 8.0% |
每股收益（稀释后）OGERVTY
| Q1 26 | — | — | ||
| Q4 25 | $0.34 | $0.86 | ||
| Q3 25 | $1.14 | $0.40 | ||
| Q2 25 | $0.53 | $0.46 | ||
| Q1 25 | $0.31 | $0.35 | ||
| Q4 24 | $0.50 | $0.77 | ||
| Q3 24 | $1.09 | $0.77 | ||
| Q2 24 | $0.51 | $0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $7.3B |
| 总资产 | — | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OGERVTY
| Q1 26 | — | — | ||
| Q4 25 | $200.0K | $919.9M | ||
| Q3 25 | $300.0K | $931.4M | ||
| Q2 25 | $500.0K | $991.8M | ||
| Q1 25 | $26.9M | $1.1B | ||
| Q4 24 | $600.0K | $1.2B | ||
| Q3 24 | $9.9M | $1.2B | ||
| Q2 24 | $100.0K | $2.0B |
总债务OGERVTY
| Q1 26 | — | — | ||
| Q4 25 | $5.4B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $5.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益OGERVTY
| Q1 26 | — | — | ||
| Q4 25 | $5.0B | $7.3B | ||
| Q3 25 | $4.8B | $7.4B | ||
| Q2 25 | $4.6B | $7.6B | ||
| Q1 25 | $4.6B | $7.6B | ||
| Q4 24 | $4.6B | $7.7B | ||
| Q3 24 | $4.6B | $7.9B | ||
| Q2 24 | $4.5B | $7.9B |
总资产OGERVTY
| Q1 26 | — | — | ||
| Q4 25 | $14.4B | $12.2B | ||
| Q3 25 | $14.3B | $12.1B | ||
| Q2 25 | $14.1B | $12.4B | ||
| Q1 25 | $14.0B | $12.4B | ||
| Q4 24 | $13.7B | $12.4B | ||
| Q3 24 | $13.5B | $12.8B | ||
| Q2 24 | $13.2B | $13.4B |
负债/权益比OGERVTY
| Q1 26 | — | — | ||
| Q4 25 | 1.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.09× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流OGERVTY
| Q1 26 | — | — | ||
| Q4 25 | $384.8M | $182.0M | ||
| Q3 25 | $397.8M | $138.5M | ||
| Q2 25 | $338.6M | $134.3M | ||
| Q1 25 | $15.9M | $128.2M | ||
| Q4 24 | $129.6M | $174.2M | ||
| Q3 24 | $347.1M | $147.9M | ||
| Q2 24 | $253.1M | $158.6M |
自由现金流OGERVTY
| Q1 26 | — | — | ||
| Q4 25 | $83.1M | $161.8M | ||
| Q3 25 | $168.3M | $120.0M | ||
| Q2 25 | $64.9M | $115.5M | ||
| Q1 25 | $-233.6M | $112.2M | ||
| Q4 24 | $-167.0M | $149.8M | ||
| Q3 24 | $103.0M | $125.6M | ||
| Q2 24 | $-70.2M | $136.6M |
自由现金流率OGERVTY
| Q1 26 | — | — | ||
| Q4 25 | 11.8% | 21.0% | ||
| Q3 25 | 16.4% | 17.2% | ||
| Q2 25 | 9.0% | 16.0% | ||
| Q1 25 | -31.5% | 16.9% | ||
| Q4 24 | -22.4% | 20.5% | ||
| Q3 24 | 10.9% | 18.4% | ||
| Q2 24 | -10.9% | 19.7% |
资本支出强度OGERVTY
| Q1 26 | — | — | ||
| Q4 25 | 43.0% | 2.6% | ||
| Q3 25 | 22.3% | 2.6% | ||
| Q2 25 | 38.0% | 2.6% | ||
| Q1 25 | 33.7% | 2.4% | ||
| Q4 24 | 39.8% | 3.4% | ||
| Q3 24 | 25.8% | 3.3% | ||
| Q2 24 | 50.2% | 3.2% |
现金转化率OGERVTY
| Q1 26 | — | — | ||
| Q4 25 | 5.56× | 1.85× | ||
| Q3 25 | 1.72× | 2.97× | ||
| Q2 25 | 3.15× | 2.49× | ||
| Q1 25 | 0.25× | 3.03× | ||
| Q4 24 | 1.27× | 1.84× | ||
| Q3 24 | 1.59× | 1.57× | ||
| Q2 24 | 2.47× | 2.87× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OGE
| Residential | $260.4M | 35% |
| Commercial | $212.0M | 28% |
| Public authorities and street light | $61.9M | 8% |
| Industrial | $60.7M | 8% |
| Oilfield | $58.4M | 8% |
| Integrated market | $47.3M | 6% |
| Transmission | $40.7M | 5% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
